7Baggers
 Neurocrine Biosciences director sells $681,913 in stock  MSN Mon, 29 Sep 2025 15:36:59 GMT
 Should You be Optimistic on Neurocrine Biosciences (NBIX)?  Yahoo Finance Thu, 25 Sep 2025 13:55:53 GMT
 neurocrine details phase 2 results for depression drug  Endpoints News Tue, 23 Sep 2025 15:24:00 GMT
 neurocrine’s phase ii mdd success raises analyst spirits  Clinical Trials Arena Tue, 23 Sep 2025 10:18:45 GMT
 neurocrine bio. stock price target raised to $169 by jefferies  Investing.com Nigeria Tue, 23 Sep 2025 00:16:56 GMT
 neurocrine bio. stock price target raised to $169 by jefferies  Investing.com Mon, 22 Sep 2025 19:24:11 GMT
 neurocrine bio. stock rating reiterated by stifel on positive mdd data  Investing.com Mon, 22 Sep 2025 14:02:32 GMT
 ubs reiterates buy rating on neurocrine bio. stock with $188 target  Investing.com Mon, 22 Sep 2025 09:56:53 GMT
 swedbank ab boosts position in neurocrine biosciences, inc. $nbix  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 exploring high growth tech stocks in the us market september 2025  simplywall.st Fri, 19 Sep 2025 17:16:42 GMT
 neurocrine biosciences, inc. $nbix shares bought by swedbank ab  MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
 Neurocrine Biosciences at TD Cowen Summit: Evolving R&D Strategy  Investing.com Wed, 17 Sep 2025 07:00:00 GMT
 neurocrine biosciences, inc. $nbix shares bought by swedbank ab  MarketBeat Tue, 16 Sep 2025 22:52:30 GMT
 neurocrine to present new phase 2 data for depression treatment  Investing.com Tue, 16 Sep 2025 21:11:56 GMT
 What Does Wall Street Think About Neurocrine Biosciences (NBIX)?  Yahoo Finance Tue, 16 Sep 2025 07:00:00 GMT
 amundi sells 30,673 shares of neurocrine biosciences, inc. $nbix  MarketBeat Sun, 14 Sep 2025 05:52:15 GMT
 amundi sells 30,673 shares of neurocrine biosciences, inc. $nbix  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 amundi lowers holdings in neurocrine biosciences, inc. $nbix  MarketBeat Sat, 13 Sep 2025 02:38:32 GMT
 neurocrine biosciences, inc. (nasdaq:nbix) short interest update  MarketBeat Sat, 13 Sep 2025 00:52:58 GMT
 neurocrine bio. stock price target raised to $149 by rbc capital  Investing.com Nigeria Sat, 06 Sep 2025 00:14:03 GMT
 neurocrine price target raised to $149 from $144 at rbc capital  TipRanks Fri, 05 Sep 2025 13:39:42 GMT
 neurocrine bio. stock price target raised to $149 by rbc capital  Investing.com Fri, 05 Sep 2025 11:04:33 GMT

Neurocrine Biosciences, Inc
(NASDAQ:NBIX) 

NBIX stock logo

Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...

Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends